3 ms·
Under a pure market approach, if a drug is not profitable it will not be produced ans sold. If you have a rare disease, you would probably prefer a mixed approa
by DomreiRoam 8y ago
Under a pure market approach, if a drug is not profitable it will not be produced ans sold. If you have a rare disease, you would probably prefer a mixed approach like a mix public and private medical research.
- refurb 8y agoThere is a middle ground where it's profitable for one company to make a drug, but not profitable for two companies to do it.
- DomreiRoam 8y agoI agree with you and in a pure profit oriented you will always have rare diseases without remedies. You may even have curable patient that are non-economical to save for for-profit health-care company. Imagine you have only pure market that provides 80% total availability for disease remedies. If you want to cover the 20% uncovered case by bringing a non-profit player, you may threaten some of the pure market player. At the end you may have a 60% coverage by for-profit and 40% by non-profit. The end solution may seems to be less economically efficient but it covers more of the population and I think it is a good thing.